Latest News and Press Releases

JERUSALEM, Jan. 10, 2017 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN), the leader in the development of advanced noninvasive treatments for brain disorders, announced today the appointment of...

HACKENSACK, N.J., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Brainsway® USA Inc., a subsidiary of Brainsway Ltd. (TASE:BRIN), a leader in the advanced non-invasive treatment of brain disorders, announced...

Revenue Increased by 87 percent to $3.4 million compared to Q3 2015Gross profit exceeds 83 percent to approximately $2.8 million compared to Q3 2015Third quarter Non-GAAP dilution of $356,000 compared...

JERUSALEM, Sept. 14, 2016 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN), the leader in the development of advanced noninvasive treatments for brain disorders, announced that it has received...

Q2 revenues surge by 90%, reaching $2.8M, compared to Q2 2015.Q2 gross margin surge by 94%, reaching $2.2M, compared to Q2 2015.Q2 net profit was $818k, compared with a loss of $759K in Q2 2015. ...

HACKENSACK, N.J., July 12, 2016 (GLOBE NEWSWIRE) -- Brainsway® USA Inc., a leader in the treatment of brain disorders, announced today that it has moved its U.S. headquarters to Hackensack, New...

HACKENSACK, N.J., June 21, 2016 (GLOBE NEWSWIRE) -- Brainsway® USA Inc., a subsidiary of Brainsway Ltd. (TASE:BRIN), a leader in the advanced non-invasive treatment of brain disorders, announced...

HACKENSACK, N.J., June 01, 2016 (GLOBE NEWSWIRE) -- Brainsway® USA Inc., a leader in the treatment of brain disorders, announced first quarter results on Monday that showed the company doubled its...

JERUSALEM, Dec. 08, 2015 (GLOBE NEWSWIRE) -- Brainsway LTD (TASE:BRIN), a leader in non-invasive brain stimulation, is pleased to announce a new partnership agreement with moksha8, a leader in the...

PHILADELPHIA, Nov. 25, 2015 (GLOBE NEWSWIRE) -- Brainsway, a leading developer of a breakthrough technology for the treatment of brain disorders, today announced a partnership with NeuroMed TMS...